Immunofluorometry of thyrotropin, from whole-blood spots on filter paper, to screen for congenital hypothyroidism.
We have evaluated a time-resolved immunofluorometric assay (IFMA) for determining thyrotropin. This "sandwich"-type system involves two monoclonal antibodies directed against different epitopes. A linear relationship between signal and thyrotropin concentration was observed up to 6000 milli-int. units/L. This procedure takes one day, vs six days with our present RIA technique, and requires only a tenth as much sample. Furthermore, intra- and interassay CVs are lower than with RIA. Assay of 19 paper-disc blood specimens from newborns identified as having congenital hypothyroidism, both by RIA and by clinical evidence, also gave positive results with IFMA. In prospective assay of 3944 specimens by both methods we identified one case of congenital hypothyroidism, which was detected by both techniques. Technical false-positive reactions, identified as such by repeated analyses, were fewer with the IFMA method than with RIA.
D000911:Antibodies, Monoclonal; D003409:Congenital Hypothyroidism; D005189:False Positive Reactions; D005455:Fluorescent Antibody Technique; D006801:Humans; D007037:Hypothyroidism / Q000517:prevention & control; D007231:Infant, Newborn; D008403:Mass Screening; D010209:Paper; D011786:Quality Control; D011863:Radioimmunoassay; D013972:Thyrotropin / Q000097:blood*
D000911:Antibodies, Monoclonal; D013972:Thyrotropin